ABBV Technical Analysis
As of date:2/20/2020
ABBV stock price:94.23
ABBV 50 DMA:88.20
ABBV 200 DMA:76.44
ABBV MACD (200-50):-11.76
ABBV RSI:77.88
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)77.88
Extremely
Oversold

Also see:
ABBV Market Cap History
ABBV Shares Outstanding History
ABBV YTD Return

Quotes delayed 20 minutes
Get Free SEC filing alerts for ABBV:
ABBV SEC Filing Email Alerts ServiceExternal link

BMRC Makes Notable Cross Below Critical Moving Average
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - WTBA
1 hour, 2 minutes ago


EDIT Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - ALTR
1 hour, 2 minutes ago


WDAY Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


IPLDP Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - BATRA
1 hour, 3 minutes ago


HLX Makes Notable Cross Below Critical Moving Average
1 hour, 34 minutes ago


Independence Holding Breaks Below 200-Day Moving Average - Notable for IHC
1 hour, 51 minutes ago


Urstadt Biddle Properties Breaks Above 200-Day Moving Average - Bullish for UBA
1 hour, 51 minutes ago


Public Service Enterprise Group Breaks Above 200-Day Moving Average - Bullish for PEG
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - MLM
1 hour, 56 minutes ago


HYS Shares Cross Below 200 DMA
1 hour, 56 minutes ago


Novo Resources (NVO.CA) Shares Cross Below 200 DMA
1 hour, 56 minutes ago


FLJP Crowded With Sellers
1 hour, 56 minutes ago


More Technical Analysis News

ABBV Technical AnalysisABBV RSI
AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

When researching a stock like AbbVie, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABBV Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ABBV DMAABBV MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie (ABBV) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ABC Technical Analysis
ABMD Technical Analysis
ABT Technical Analysis
AGN Technical Analysis
ALGN Technical Analysis
ALXN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
More Healthcare companies »

 

ABBV Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.